The local scientific programme “El problema de Gettier”, from la Xarxa TV, interviews Modesto Orozco about bioinformatics and biosimulation. The IRB expert believes that in the future doctors will have simulation models of each patient that will help to predict disease progression.
Link to “ El problema de Gettier”.
BSC, CRG, and IRB sign a collaboration agreement for five years that will promote Barcelona as a world leader in computational biology.
The goals of this joint programme are to retain the critical mass of researchers, to attract talent, and to boost computational biology.
The team includes ten well-known researchers headed by Modesto Orozco (IRB), Roderic Guigó (CRG), and David Torrents (BSC).
The Spanish television channel “La 2” broadcasted a programme funded by the Botín Foundation about several of the projects it supports, among them two "Mind the Gap" technology transfer projects belonging to IRB Barcelona. Eduard Batlle and Elena Sancho talk about "Colostage" and Modesto Orozco about "Nostrum Drug Discovery".
Salvador Aznar-Benitah, Angel R. Nebreda, Modesto Orozco, and Manuel Palacín are beneficiaries of funds raised in the 2012 “Marató” destined to fight cancer.
The IRB Barcelona projects—one individual and three coordinated—are to receive approx. 1.2 M€.
Having raised more than 11 M€, “La Fundació” will financially support 47 projects carried out by 79 researchers over the next three years.
The “Diario Médico” talked to IRB Barcelona researcher Modesto Orozco about advance in computational simulation during the Barcelona Biomed Conference, held in the IEC and supported by the BBVA Foundation.
Read the news in Diario Médico (...
Meeting of international experts in biosimulation in the 22nd Barcelona Biomed Conference, organized by IRB Barcelona and the BBVA Foundation.
Advances and applications in chemistry and computational biology have been awarded the 2013 Nobel Prize in Chemistry.
Exascale computation, to be available as of 2020, will achieve a rate of one trillion calculations per second, making it 1000 times faster than today’s most powerful supercomputers.
This will lead to a wealth of benefits for science and economy: it will allow scientists to read, process and better understand the genome, produce drugs more cheaply, and create computer simulations of entire organisms, including humans, which will provide an important boost to personalized medicine.
On 18-20 September, experts from the US, Canada, Germany, Switzerland, the UK, Germany and Spain will meet at Barcelona’s Cosmocaixa to discuss the current state and expectations of high-throughput supercomputing, and its impact on European research and industry.
Researchers with the joint programme Institute for Research in Biomedicine (IRB Barcelona)- Barcelona Supercomputing Center (BSC) on Computational Biology, together with scientists at Center for Genomic Regulation (CRG) have discovered a hidden DNA structural code that provides novel insights on gene expression. The results are available in the electronic version of ...
The supplement "El Cultural" of the newspaper "El Mundo" publishes an interview with researcher Modesto Orozco about supercomputation and the capacity to simulate biological processes. Orozco goes over some of the projects that his "Molecular Modelling and Bioinformatics" lab is working on, such as "Nostrum Drug Discovery", which is funded by the Botín...